Carl Zimmer writes in the New York Times: Imagine a scientist gently swabs your left nostril with a Q-tip and finds that your nose contains hundreds of species of bacteria. That in itself is no surprise; each of us is home to some 100 trillion microbes. But then she makes an interesting discovery: in your nose is a previously unknown species that produces a powerful new antibiotic. Her university licenses it to a pharmaceutical company; it hits the market and earns hundreds of millions of dollars. Do you deserve a cut of the profits? (Our Microbiome, Ourselves. 3 December 2011). Write a draft policy paper arguing why a patient should or should not receive compensation in this scenario. 2-3 pages.
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|